Improved Formulation for Chemotherapy of Malaria
Accordingly, the present technology provides biologically active derivatives of 4- ethyI-5-alkoxy-primaquine and its process for the preparation to offer an improved means for the chemotherapy of malaria. The derivative has a unique blend of broadspectrum activity against the blood as well as tissue stages of the human malaria parasites. The present technology is at pre-clinical stage.
Sector: Pharmaceuticals
Country: India
Area of Application: chemotherapy,Malaria,blood-schizontocidal
Keywords: chemotherapy,Malaria
Advantages: Better therapeutic index Reduced cost of treatment Longer Half-life Improved patient compliance
Environmental aspects: Not Applicable
Development Status: Laboratory Model
Legal Protection: Patent in Progress
Technical specifications:
Transfer Terms: Technology Licensing
Target Countries: India
Estimated cost (US$):
Upload any relevant document:
Contact Person: SkyQuest Technology Consulting Pvt. Ltd.
Address: 501, Krishna Complex, Opp. Devashish School, Bodakdev
City: Ahmedabad
Country: India
Zip/Pin Code: 380054